In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages The Gram-negative proteobacterium Burkholderia pseudomallei can survive and multiply within a variety of eukaryotic cells, including macrophages. This property is believed to be important for its ability to cause the disease melioidosis in a wide range of animal species, including humans. To identify determinants that are important for the ability of B. pseudomallei to survive within macrophages, in vivo expression technology (IVET) was employed. Several putative macrophage-inducible genes were identified that are likely to contribute to the virulence of B. pseudomallei, including three genes (tssH-5, tssI-5 and tssM-5) located within the same type VI secretion system cluster (tss-5), mntH, encoding a natural resistance-associated macrophage protein (NRAMP)-like manganese ion transporter, and a haem acquisition gene, bhuT. The macrophage-inducibility of the tss-5 gene cluster was confirmed by reporter gene analysis. Construction of tssH-5 and bhuT null mutants indicated that expression of the tss-5 unit and the bhu operon were not required for intramacrophage survival. A further five tss units were identified within the B. pseudomallei genome that, together with tss-5, account for approximately 2.3 % of the total genome size. The presence of six type VI secretion systems in this organism is likely to be an important factor in making this bacterium such a versatile pathogen.
INTRODUCTIONMelioidosis is the name given to any infection caused by Burkholderia pseudomallei, a saprophytic, Gram-negative bacillus found in wet soil and pooled water, particularly in south-east Asia and northern Australia (White, 2003). It is principally acquired following inoculation of lesions in the skin by contaminated soil and water, with the highest incidence of the disease occurring during the rainy and monsoon seasons (Dance, 1991;White, 2003). Another important route of infection is inhalation of contaminated particles. The clinical spectrum of melioidosis ranges from an acute fulminant septicaemia to chronic localized infections, often affecting the lung, and is usually characterized by abscess formation. No vaccines are available, and antibiotic therapy is problematic due to the intrinsic high resistance of B. pseudomallei to many antibiotics. The overall mortality of melioidosis patients is 50 % (White, 2003).Certain features of melioidosis suggest that B. pseudomallei is a facultative intracellular pathogen. These include the occurrence of long periods of latency (a recent case report suggests this can be as long as 62 years), relapses due to recrudescence of a persistent primary infection, and the activation of a cellular immune response during melioidosis (Chaowagul et al., 1993;Ngauy et al., 2005). Consistent with this, B. pseudomallei has been shown to survive and multiply within non-phagocytic cells, macrophages and free-living amoebae (Pruksachartvuthi et al., 1990;Jones et a...